<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03816709</url>
  </required_header>
  <id_info>
    <org_study_id>HE19132</org_study_id>
    <nct_id>NCT03816709</nct_id>
  </id_info>
  <brief_title>Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound</brief_title>
  <official_title>Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound With 3 MHz, 1.0 W/cm2 at Three Depths up to 2.5 cm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Dakota State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Dakota State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the rate of tissue temperature increase in the&#xD;
      triceps surae during an ultrasound treatment using the Chattanooga Intelect Legend XT. The&#xD;
      following parameters will be used: 3 MHz frequency, 1.0 W/cm2 intensity, 15 minute treatment&#xD;
      time. Thermocouples will be inserted at 1.0, 1.75, and 2.5 cm depths to determine the heating&#xD;
      rates. Most modality textbook recommendations for therapeutic ultrasound are based on studies&#xD;
      performed with the Omnisound ultrasound machine. Previous research has shown variations in&#xD;
      power output across manufacturers, producing differences in tissue temperature increases. No&#xD;
      information has been published regarding the heating rates of the Chattanooga Intelect Legend&#xD;
      XT machine for ultrasound treatments. By determining the heating rates for this machine,&#xD;
      clinicians will be better able to utilize the Chattanooga Intelect Legend XT to help reach&#xD;
      therapeutic goals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individual subjects will report to the research lab. They will be instructed to wear&#xD;
      appropriate shorts or pants that can be rolled up to expose the gastrocnemius (calf) muscle.&#xD;
      The subject will lay prone on the treatment table with the foot and lower leg off of the&#xD;
      treatment table in a relaxed, comfortable position. The following procedures will be&#xD;
      completed using universal precautions:&#xD;
&#xD;
        1. The investigator will prep the treatment area by having the subject flex the calf to&#xD;
           determine the proper location for the ultrasound treatment in the middle of the medial&#xD;
           gastrocnemius muscle belly at its largest girth.&#xD;
&#xD;
             1. A carpenter's square with markings along the vertical arm at the three experimental&#xD;
                depths (1.0, 1.75, 2.5 cm) will be used.&#xD;
&#xD;
             2. The horizontal arm of the carpenter's square will be covered in tape. The&#xD;
                carpenter's square is then placed just proximal to the treatment mark while the&#xD;
                level on the horizontal arm is used to maintain a level measure.&#xD;
&#xD;
             3. Marks will be made on the muscle belly parallel to the marks on the vertical axis&#xD;
                at 1.0, 1.75 and 2.5 cm depths.&#xD;
&#xD;
             4. A mark is also made on the horizontal arm tape in line with the treatment mark on&#xD;
                the medial gastrocnemius.&#xD;
&#xD;
        2. The Terason uSmart 3300 diagnostic ultrasound unit will be used to measure the adipose&#xD;
           thickness over the treatment area and look for abnormalities in the treatment and&#xD;
           thermocouple insertion areas. Aquasonic® 100 ultrasound gel will be placed on the 15L4&#xD;
           transducer. The transducer with gel will be placed over the mark of the treatment area.&#xD;
           Once the transducer is in place, the screen will be frozen and the skin and adipose&#xD;
           thickness will be measured using the caliper tool.&#xD;
&#xD;
        3. The thermocouples will be removed from the MetriCide after sterilizing for a minimum of&#xD;
           12 hours prior to insertion.&#xD;
&#xD;
             1. The distal aspect of the thermocouple will be wiped dry with sterile gauze.&#xD;
&#xD;
             2. A mark with a sharpie will be made on each thermocouple just past the length marked&#xD;
                on the horizontal arm of the carpenter's square. This allows the tip of each&#xD;
                thermocouple to be directly below the treatment site. A second mark will be made at&#xD;
                5 cm to make sure the thermocouple does not go too deep into the tissue.&#xD;
&#xD;
             3. The distal end of the thermocouple will be wiped clean again using a 70% isopropyl&#xD;
                alcohol wipe up to the marks and then the thermocouple will be wrapped in sterile&#xD;
                gauze until it is inserted.&#xD;
&#xD;
        4. The insertion areas will be shaved to remove any body hair (if necessary) and cleaned&#xD;
           using Betadine.&#xD;
&#xD;
           a. Once the Betadine dries, 70% isopropyl alcohol will be wiped over the insertion area&#xD;
           and given time to dry.&#xD;
&#xD;
        5. The subject will be instructed to take two deep breaths, while the researcher lightly&#xD;
           grasps the gastrocnemius to confirm muscle relaxation.&#xD;
&#xD;
             1. During the second exhalation, the 1.16 in needle catheter will be placed into the&#xD;
                subject's calf at the 1.0 cm depth insertion mark using the level to guide the&#xD;
                needle in. The needle will be removed leaving the catheter in the tissue.&#xD;
&#xD;
             2. The thermocouple will be threaded through the catheter to the appropriate depth&#xD;
                marked on the thermocouple and the catheter will be removed.&#xD;
&#xD;
             3. The thermocouple will be secured using medical tape to keep it from moving.&#xD;
&#xD;
             4. This procedure will be performed 3 times, with one thermocouple placed at each&#xD;
                respective depth: 1.0 cm, 1.75 cm, and 2.5 cm.&#xD;
&#xD;
        6. Each thermocouple will be attached to the Iso Thermex electronic thermometer (Columbus&#xD;
           Instruments, Columbus, OH), which will measure and record intramuscular temperatures&#xD;
           from the tips of the thermocouples.&#xD;
&#xD;
        7. An ultrasound treatment template will be applied at the treatment site and secured with&#xD;
           tape to maintain consistent treatment size.&#xD;
&#xD;
           a. This template will be twice the size of the transducer's Effective Radiating Area&#xD;
           (ERA).&#xD;
&#xD;
        8. A metronome will be utilized to consistently move the transducer at a rate of 4 cm/s .&#xD;
&#xD;
        9. The ultrasound treatment will begin once the intramuscular temperature has remained the&#xD;
           same for a minute.&#xD;
&#xD;
       10. Each subject will receive one ultrasound treatment at the following parameters: 3 MHz&#xD;
           frequency, 1.0 W/cm2 intensity, and 100% duty cycle using the Chattanooga Intelect®&#xD;
           Legend XT.&#xD;
&#xD;
           a. Termination of treatment will result when any of the following occur: i. A 15-minute&#xD;
           treatment time is obtained. ii. A 4°C temperature increase occurs at all three depths as&#xD;
           this has been shown as the necessary temperature change to increase tissue&#xD;
           extensibility.&#xD;
&#xD;
           iii. A 45°C temperature is reached at any depth, due to concern of tissue damage at high&#xD;
           temperatures.&#xD;
&#xD;
           iv. The subject experiences any pain or discomfort during the treatment.&#xD;
&#xD;
       11. Following the treatment, the ultrasound gel will be wiped from the leg, the template and&#xD;
           thermocouples will be removed, and the insertion sites will be cleaned with 70%&#xD;
           isopropyl alcohol wipes and covered with a band aid.&#xD;
&#xD;
       12. The subject will then be instructed on the possibility of minor soreness for the next&#xD;
           day or two and instructed on an icing schedule to decrease discomfort.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 5, 2019</start_date>
  <completion_date type="Actual">May 11, 2020</completion_date>
  <primary_completion_date type="Actual">April 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heating Rate at 1 cm Depth</measure>
    <time_frame>Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)</time_frame>
    <description>A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heating Rate at 1.75 cm Depth</measure>
    <time_frame>Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 8 minutes)</time_frame>
    <description>A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heating Rate at 2.5 cm Depth</measure>
    <time_frame>Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which did not occur in the 15 minute treatment)</time_frame>
    <description>A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Ultrasound Therapy; Complications</condition>
  <arm_group>
    <arm_group_label>Therapeutic ultrasound treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Therapeutic Ultrasound</intervention_name>
    <description>A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes.</description>
    <arm_group_label>Therapeutic ultrasound treatment</arm_group_label>
    <other_name>Ultrasound therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  males and females between the ages of 18 - 35 years old&#xD;
&#xD;
          -  able to speak English&#xD;
&#xD;
          -  have less than 1 cm of adipose over the left medial gastrocnemius muscle.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any current lower extremity injury&#xD;
&#xD;
          -  any lower extremity injuries within the last 6 months&#xD;
&#xD;
          -  open wounds&#xD;
&#xD;
          -  skin infections&#xD;
&#xD;
          -  impaired circulation&#xD;
&#xD;
          -  peripheral vascular disease&#xD;
&#xD;
          -  deep vein thrombosis&#xD;
&#xD;
          -  advanced arthritis&#xD;
&#xD;
          -  poor thermal regulation&#xD;
&#xD;
          -  anesthetic areas&#xD;
&#xD;
          -  neoplasms/tumors&#xD;
&#xD;
          -  thrombophlebitis&#xD;
&#xD;
          -  closed infections&#xD;
&#xD;
          -  any allergies or sensitivities to betadine&#xD;
&#xD;
          -  any abnormalities observed in the medial gastrocnemius muscle determined by diagnostic&#xD;
             ultrasound&#xD;
&#xD;
          -  1.0 cm or greater adipose over the left medial gastrocnemius muscle.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristy Shirley</last_name>
    <role>Study Director</role>
    <affiliation>NDSU IRB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Dakota State University</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58108-6050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gange KN, Kjellerson MC, Berdan CJ. The Dynatron Solaris® Ultrasound Machine: Slower Heating Than Textbook Recommendations at 3 MHz, 1.0 W/cm(2). J Sport Rehabil. 2018 Jan 1;27(1):22-29. doi: 10.1123/jsr.2016-0173. Epub 2018 Jan 18.</citation>
    <PMID>27992304</PMID>
  </reference>
  <reference>
    <citation>Merrick MA, Bernard KD, Devor ST, Williams MJ. Identical 3-MHz ultrasound treatments with different devices produce different intramuscular temperatures. J Orthop Sports Phys Ther. 2003 Jul;33(7):379-85.</citation>
    <PMID>12918863</PMID>
  </reference>
  <reference>
    <citation>Draper DO, Castel JC, Castel D. Rate of temperature increase in human muscle during 1 MHz and 3 MHz continuous ultrasound. J Orthop Sports Phys Ther. 1995 Oct;22(4):142-50.</citation>
    <PMID>8535471</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 23, 2019</study_first_submitted>
  <study_first_submitted_qc>January 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2019</study_first_posted>
  <results_first_submitted>March 5, 2020</results_first_submitted>
  <results_first_submitted_qc>May 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 27, 2021</results_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Dakota State University</investigator_affiliation>
    <investigator_full_name>Kara Gange</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>heating rates</keyword>
  <keyword>therapeutic ultrasound</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Once the data has been analyzed to determine the heating rates, a manuscript including the heating rates will be submitted for publication.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT03816709/Prot_005.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT03816709/SAP_006.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT03816709/ICF_007.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Twenty-five subjects were recruited through the Institution's Listserve from January-February, 2019.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Therapeutic Ultrasound Treatment</title>
          <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.&#xD;
Therapeutic Ultrasound: A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>male and female 18-35 year olds with no injuries to the lower leg.</population>
      <group_list>
        <group group_id="B1">
          <title>Therapeutic Ultrasound Treatment</title>
          <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.&#xD;
Therapeutic Ultrasound: A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>18-35 year olds</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Heating Rate at 1 cm Depth</title>
        <description>A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.</description>
        <time_frame>Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 6 minutes)</time_frame>
        <population>Intent to treat population. All subjects received the Ultrasound treatment with a thermocouple recording tissue temperatures at the 1 cm depth.</population>
        <group_list>
          <group group_id="O1">
            <title>Therapeutic Ultrasound Treatment</title>
            <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.&#xD;
Therapeutic Ultrasound: A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes at the depths of 1.0, 1.75, and 2.5 cm.</description>
          </group>
        </group_list>
        <measure>
          <title>Heating Rate at 1 cm Depth</title>
          <description>A thermocouple was inserted at the 1 cm depth to determine the tissue temperatures.</description>
          <population>Intent to treat population. All subjects received the Ultrasound treatment with a thermocouple recording tissue temperatures at the 1 cm depth.</population>
          <units>degrees Celcius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.49" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Heating Rate at 1.75 cm Depth</title>
        <description>A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.</description>
        <time_frame>Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which occurred at 8 minutes)</time_frame>
        <population>Intent to treat. All subject received the Ultrasound treatment with a thermocouple at the 1.75 cm depth to determine tissue temperature</population>
        <group_list>
          <group group_id="O1">
            <title>Therapeutic Ultrasound Treatment</title>
            <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.&#xD;
Therapeutic Ultrasound: A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes at the depths of 1.0, 1.75, and 2.5 cm.</description>
          </group>
        </group_list>
        <measure>
          <title>Heating Rate at 1.75 cm Depth</title>
          <description>A thermocouple was inserted at the 1.75 cm depth to determine the tissue temperatures.</description>
          <population>Intent to treat. All subject received the Ultrasound treatment with a thermocouple at the 1.75 cm depth to determine tissue temperature</population>
          <units>degrees Celcius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.50" spread="1.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Heating Rate at 2.5 cm Depth</title>
        <description>A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.</description>
        <time_frame>Baseline to end of treatment (up to 15 minutes or until temperatures increased 4 degrees, which did not occur in the 15 minute treatment)</time_frame>
        <population>Intent to treat. All subjects received the Ultrasound treatment with a thermocouple at the 2.5 cm depth to determine tissue temperatures.</population>
        <group_list>
          <group group_id="O1">
            <title>Therapeutic Ultrasound Treatment</title>
            <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.&#xD;
Therapeutic Ultrasound: A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes at the depths of 1.0, 1.75, and 2.5 cm.</description>
          </group>
        </group_list>
        <measure>
          <title>Heating Rate at 2.5 cm Depth</title>
          <description>A thermocouple was inserted at the 2.5 cm depth to determine the tissue temperatures.</description>
          <population>Intent to treat. All subjects received the Ultrasound treatment with a thermocouple at the 2.5 cm depth to determine tissue temperatures.</population>
          <units>degrees Celcius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.07" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Therapeutic Ultrasound Treatment</title>
          <description>All subjects received a therapeutic ultrasound treatment with the Chattanooga Intelect Legend XT machine with the following parameters: 3 MHz, 1.0 W/cm2, 15 minute treatment time.&#xD;
Therapeutic Ultrasound: A therapeutic ultrasound treatment was applied to the left medial gastrocnemius muscle with the following parameters: 3 MHz, 1.0 W/cm2 for 15 minutes at the depths of 1.0, 1.75, and 2.5 cm.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kara Gange, Associate Professor</name_or_title>
      <organization>North Dakota State University</organization>
      <phone>701-231-5777</phone>
      <email>kara.gange@ndsu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

